Back to KROS
BANK OF AMERICA CORP /DE/ → KROS
BANK OF AMERICA CORP /DE/ KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$727K
Q3 2026
Peak value
$3.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.4M |
| Q3 2025 | $7K |
| Q3 2025 | $129K |
| Q3 2025 | $16 |
| Q4 2025 | $1.5M |
| Q4 2025 | $9K |
| Q4 2025 | $484K |
| Q4 2025 | $20 |
| Q1 2026 | $448K |
| Q1 2026 | $145K |
| Q2 2026 | $334K |
| Q3 2026 | $727K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $727K | 63.8K | — | — |
| Q2 2026 | $334K | 31.2K | — | — |
| Q1 2026 | $145K | 13.1K | — | — |
| Q1 2026 | $448K | 40.6K | — | — |
| Q4 2025 | $20 | 1 | — | — |
| Q4 2025 | $484K | 23.8K | — | — |
| Q4 2025 | $9K | 430 | — | — |
| Q4 2025 | $1.5M | 75.9K | — | — |
| Q3 2025 | $16 | 1 | — | — |
| Q3 2025 | $129K | 8.1K | — | — |
| Q3 2025 | $7K | 430 | — | — |
| Q3 2025 | $3.4M | 217.6K | — | — |